The Quarterly Journal of Nuclear Medicine 2002 September;46(3)

  NOVEL METHODS OF ALTERING PHARMACOKINETICS IN RADIOPHARMACEUTICAL DESIGN
Guest Editor: Hnatowich D.

The Quarterly Journal of Nuclear Medicine 2002 September;46(3):171-80

Polyethylene glycol in the design of tumor-targetting radiolabelled macromolecules - lessons from liposomes and monoclonal antibodies

Harrington K. J., Mubashar M., Peters A. M.

Abstract PDF

  NOVEL METHODS OF ALTERING PHARMACOKINETICS IN RADIOPHARMACEUTICAL DESIGN
Guest Editor: Hnatowich D.

The Quarterly Journal of Nuclear Medicine 2002 September;46(3):181-94

Analysis of renal handling of radiopharmaceuticals

Trejtnar F., Laznicek M.

Abstract PDF

  NOVEL METHODS OF ALTERING PHARMACOKINETICS IN RADIOPHARMACEUTICAL DESIGN
Guest Editor: Hnatowich D.

The Quarterly Journal of Nuclear Medicine 2002 September;46(3):195-205

The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides

Decristoforo C., Mather S. J.

Abstract PDF

  NOVEL METHODS OF ALTERING PHARMACOKINETICS IN RADIOPHARMACEUTICAL DESIGN
Guest Editor: Hnatowich D.

The Quarterly Journal of Nuclear Medicine 2002 September;46(3):206-23

Altering pharmacokinetics of radiolabeled antibodies by the interposition of metabolizable linkages. Metabolizable linkers and pharmacokinetics of monoclonal antibodies

Akizawa H., Arano Y.

Abstract PDF

  NOVEL METHODS OF ALTERING PHARMACOKINETICS IN RADIOPHARMACEUTICAL DESIGN
Guest Editor: Hnatowich D.

The Quarterly Journal of Nuclear Medicine 2002 September;46(3):224-32

The influence of carrier on 99mTc radiopharmaceuticals

Ballinger J. R.

Abstract PDF

  NOVEL METHODS OF ALTERING PHARMACOKINETICS IN RADIOPHARMACEUTICAL DESIGN
Guest Editor: Hnatowich D.

The Quarterly Journal of Nuclear Medicine 2002 September;46(3):233-43

The influence of chain length and base se-quence on the pharmacokinetic behavior of 99mTc-morpholinos in mice

Liu G., Zhang S., He J., Liu N., Gupta S., Rusckowski M., Hnatowich D. J.

Abstract PDF